Gilbert Wagener

Effect of long-acting nifedipine on mortality and cardiovascular morbidity in patients with stable angina requiring treatment (ACTION trial): randomised controlled trial

Philip A. Poole‐Wilson, Jacobus Lubsen, Bridget‐Anne Kirwan et al. · The Lancet · 2004 · 515 citations

Thrombosis, Non-pharmacological Intervention, Action Trial +11

Randomized, Placebo-Controlled Trial of Mipomersen in Patients with Severe Hypercholesterolemia Receiving Maximally Tolerated Lipid-Lowering Therapy

Mary P. McGowan, Jean‐Claude Tardif, R Češka et al. · PLoS ONE · 2012 · 220 citations · Full text

Mipomersen, an apolipoprotein B synthesis inhibitor, lowers low-density lipoprotein cholesterol in high-risk statin-intolerant patients: a randomized, double-blind, placebo-controlled trial

Maartje E. Visser, Gilbert Wagener, Brenda F. Baker et al. · European Heart Journal · 2012 · 189 citations · Full text

Outcomes With Nifedipine GITS or Co-Amilozide in Hypertensive Diabetics and Nondiabetics in Intervention as a Goal in Hypertension (INSIGHT)

Giuseppe Mancia, Morris J. Brown, A Castaigne et al. · Hypertension · 2003 · 158 citations · Full text

Effect of long-acting nifedipine on mortality and cardiovascular morbidity in patients with symptomatic stable angina and hypertension: the ACTION trial

Jacobus Lubsen, Gilbert Wagener, Bridget‐Anne Kirwan et al. · Journal of Hypertension · 2005 · 136 citations